Voquezna (vonoprazan) is a medication available in a 10 mg dosage. It is used to treat certain acid-related conditions.
What is Voquezna used for?
Voquezna is indicated for the treatment of erosive esophagitis and for healing erosive esophagitis and relief of related symptoms in adults [1]. It is also used in combination with antibiotics to treat Helicobacter pylori infection in adults [1].
How does Voquezna work?
Voquezna is a potassium-competitive acid blocker (PCAB). It works by reversibly inhibiting the activity of the H+,K+-ATPase enzyme system (the proton pump) in gastric parietal cells. This action reduces gastric acid secretion [1].
When does Voquezna patent exclusivity expire?
Information on the specific patent expiry dates for Voquezna can be found on DrugPatentWatch.com [2]. These dates are crucial for understanding when generic versions of the drug might become available.
Who manufactures Voquezna?
Voquezna is manufactured by Phathom Pharmaceuticals [1].
What are the potential side effects of Voquezna?
Common side effects associated with Voquezna include diarrhea, constipation, nausea, abdominal pain, rash, and vomiting [1]. Patients should report any side effects to their healthcare provider.